|
IGF::OT::IGF CORE SUPPORT ACTIVITIES: SCIENTIFIC WRITING, TECHNICAL AND LOGISTICAL SUPPORT SERVICES
|
261201700004I
|
$1,200,000
|
|
BIZZELL, ANTON
|
-
|
|
A Novel Needle-Based X-Ray System
|
5R44CA112683-03
|
$380,000
|
$380,000
|
Gutman, George
|
ADVANCED X-RAY TECHNOLOGY, INC.
|
|
Clinical study of GMCI in Pancreatic Cancer
|
5R43CA119847-02
|
$376,666
|
$94,167
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Integrin Regulation of Cancer Progression Through Alternative mRNA Splicing and Nonsense-Medidated Decay (NMD)
|
5R01CA129637-08
|
$375,250
|
|
DIPERSIO, C MICHAEL
|
ALBANY MEDICAL COLLEGE
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-30
|
$396,625
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Designing Novel Anti-Cancer Therapeutics: Targeting Methionine Metabolism
|
5F30CA210372-02
|
$49,524
|
|
FIRESTONE, ROSS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
IGF::OT::IGF IGF::OF::IGF- PHASE III TRIAL OF CARBON ION THERAPY
|
261201500022C
|
$462,158
|
|
GUHA, CHANDAN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer
|
1R01CA222469-01
|
$549,306
|
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S1
|
$300,000
|
$45,000
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
5U10CA021661-32
|
$8,875,198
|
$1,331,280
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-20
|
$1,483,085
|
$118,647
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group-Statistical Center
|
5U10CA032115-26
|
$1,038,338
|
$155,751
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-05
|
$320,588
|
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock factors (Hsfs) in tumorigenesis
|
5R01CA132640-17
|
$270,000
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
Chemotherapy-induced MDSCs and antitumor immunity
|
5R01CA215523-02
|
$347,700
|
|
ZHOU, GANG
|
AUGUSTA UNIVERSITY
|
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
5R01CA132115-09
|
$428,056
|
|
PESTELL, RICHARD
|
BARUCH S. BLUMBERG INSTITUTE
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$24,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-02
|
$66,456
|
$3,987
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
|
5R01CA182467-06
|
$328,888
|
|
CHENG, CHONGHUI
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
5R01CA190776-04
|
$546,636
|
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER
|
5R01CA207270-02
|
$362,569
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of KLF4 suppression in pediatric leukemia
|
5R01CA207086-02
|
$370,641
|
|
LACORAZZA, DANIEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Novel LGR4 Oncogenic Signaling in Breast Cancer Progression and Metastasis
|
5R01CA204926-02
|
$362,569
|
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Ruxolitinib for Preventing Breast Cancer in Women on Neuroleptics
|
5R01CA205594-02
|
$362,569
|
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
|
1R01CA221946-01
|
$488,881
|
|
ROWLEY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
|
5R01CA207701-02
|
$426,451
|
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Effects of High Fructose Corn Syrup on Intestinal Tumorigenesis
|
1K22CA216036-01
|
$179,877
|
|
YUN, JIHYE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
|
5R01CA213131-02
|
$430,377
|
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Reolysin-based combination therapy in relapsed multiple myeloma
|
5R01CA194742-03
|
$574,645
|
|
PICHIORRI, FLAVIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Androgen Signaling in prostate cancer progression and CRPC development
|
5R01CA070297-20
|
$305,119
|
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
|
5K08CA201591-02
|
$169,560
|
|
WANG, LEO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention
|
5R01CA164019-06
|
$146,146
|
|
YEE, LISA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$2,400
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$11,730
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Control of tumor growth and metastasis by the cytokine TSLP
|
5R01CA182783-05
|
$362,503
|
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-02
|
$333,543
|
$83,386
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
2U10CA080775-09
|
$128,678
|
$14,155
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Renal Cancer SPORE
|
5P50CA101942-05
|
$2,330,598
|
$466,120
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spatially Modulated Near-Infrared Light for Image-Guided Cancer Surgery
|
1R21CA129758-01
|
$371,307
|
$371,307
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-03
|
$1,241,997
|
$1,241,997
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Prostate MRI and MRS: Correlations with Gene Expression
|
5R21CA116866-02
|
$125,453
|
$31,363
|
GASTON, SANDRA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Modeling KRAS genetic heterogeneity in mouse models
|
5R01CA195744-03
|
$635,205
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MiR-199~214 cluster at the crossroads of plasticity and malignancy in breastcancer
|
5R01CA207322-02
|
$395,738
|
|
KARNOUB, ANTOINE
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Survivor QOL/Spouse Satisfaction after Prostate Therapy
|
3R01CA095662-05S1
|
$222,647
|
$222,647
|
SANDA, MARTIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Total relevant funding to Surgery for this search: $65,645,386
|